Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marc Louis Copersino, Ph.D.


The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. K23DA027045 (COPERSINO, MARC LOUIS) Apr 1, 2010 - Apr 30, 2016
    Multimodal Brain Imaging of Functional Neurodynamics in Cocaine Dependence
    Role: Principal Investigator
  2. R03DA024126 (COPERSINO, MARC LOUIS) Sep 15, 2007 - Aug 31, 2009
    Rapid cognitive screening of patients with substance use disorders
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Verdejo-Garcia A, Rezapour T, Giddens E, Khojasteh Zonoozi A, Rafei P, Berry J, Caracuel A, Copersino ML, Field M, Garland EL, Lorenzetti V, Malloy-Diniz L, Manning V, Marceau EM, Pennington DL, Strickland JC, Wiers R, Fairhead R, Anderson A, Bell M, Boendermaker WJ, Brooks S, Bruno R, Campanella S, Cousijn J, Cox WM, Dean AC, Ersche KD, Franken I, Froeliger B, Gamito P, Gladwin TE, Goncalves PD, Houben K, Jacobus J, Jones A, Kaag AM, Lindenmeyer J, McGrath E, Nardo T, Oliveira J, Pennington CR, Perrykkad K, Piercy H, Rupp CI, Schulte MHJ, Squeglia LM, Staiger P, Stein DJ, Stein J, Stein M, Stoops WW, Sweeney M, Witkiewitz K, Woods SP, Yi R, Zhao M, Ekhtiari H. Cognitive training and remediation interventions for substance use disorders: a Delphi consensus study. Addiction. 2022 Dec 12. PMID: 36508168.
    Citations:    Fields:    
  2. Copersino ML, Slayter E, McHugh RK, Shedlack KJ, Lukas SE, Weiss RD. Clinical utility of a hybrid secondary and relapse prevention program in adults with mild intellectual disability or borderline intellectual functioning in community residential and day habilitation settings. Disabil Health J. 2022 06; 15(2S):101293. PMID: 35337784.
    Citations:    Fields:    Translation:HumansPHPublic Health
  3. Copersino ML, Long MP, Bolton P, Ressler KJ, Seiner SJ, Yip AG. First Acute-Course Electroconvulsive Therapy for Moderate-to-Severe Depression Benefits Patients With or Without Accompanying Baseline Cognitive Impairment. J ECT. 2022 06 01; 38(2):74-80. PMID: 34966040.
    Citations:    Fields:    Translation:Humans
  4. Copersino ML, Patel R, Price JS, Visser KF, Vitaliano G, Plitman E, Lukas SE, Weiss RD, Janes AC, Chakravarty MM. Interactive effects of age and recent substance use on striatal shape morphology at substance use disorder treatment entry. Drug Alcohol Depend. 2020 01 01; 206:107728. PMID: 31740207.
    Citations: 2     Fields:    Translation:Humans
  5. Guerin JM, Copersino ML, Schretlen DJ. Clinical utility of the 15-item geriatric depression scale (GDS-15) for use with young and middle-aged adults. J Affect Disord. 2018 12 01; 241:59-62. PMID: 30096593.
    Citations: 20     Fields:    Translation:Humans
  6. Copersino ML. Cognitive Mechanisms and Therapeutic Targets of Addiction. Curr Opin Behav Sci. 2017 Feb; 13:91-98. PMID: 28603756; PMCID: PMC5461927.
    Citations: 8     
  7. Copersino ML, Price JS, Frost KH, Vitaliano GD, Frederick BD, Lukas SE, Weiss RD, Janes AC. Default Mode Network Functional Reorganization During Early Abstinence in Polysubstance-Using Emerging Adults Treated for Opioid Dependence. J Neuropsychiatry Clin Neurosci. 2016; 28(4):325-327. PMID: 26792100; PMCID: PMC4956593.
    Citations: 1     Fields:    
  8. Rass O, Kleykamp BA, Vandrey RG, Bigelow GE, Leoutsakos JM, Stitzer ML, Strain EC, Copersino ML, Mintzer MZ. Cognitive performance in methadone maintenance patients: effects of time relative to dosing and maintenance dose level. Exp Clin Psychopharmacol. 2014 Jun; 22(3):248-256. PMID: 24548244.
    Citations: 8     Fields:    Translation:Humans
  9. Chauchard E, Levin KH, Copersino ML, Heishman SJ, Gorelick DA. Motivations to quit cannabis use in an adult non-treatment sample: are they related to relapse? Addict Behav. 2013 Sep; 38(9):2422-7. PMID: 23685328.
    Citations: 11     Fields:    Translation:Humans
  10. Copersino ML, Schretlen DJ, Fitzmaurice GM, Lukas SE, Faberman J, Sokoloff J, Weiss RD. Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure. Am J Drug Alcohol Abuse. 2012 May; 38(3):246-50. PMID: 22443860.
    Citations: 10     Fields:    Translation:Humans
  11. Gorelick DA, Levin KH, Copersino ML, Heishman SJ, Liu F, Boggs DL, Kelly DL. Diagnostic criteria for cannabis withdrawal syndrome. Drug Alcohol Depend. 2012 Jun 01; 123(1-3):141-7. PMID: 22153944.
    Citations: 34     Fields:    Translation:HumansAnimals
  12. Copersino ML, Boyd SJ, Tashkin DP, Huestis MA, Heishman SJ, Dermand JC, Simmons MS, Gorelick DA. Sociodemographic characteristics of cannabis smokers and the experience of cannabis withdrawal. Am J Drug Alcohol Abuse. 2010 Nov; 36(6):311-9. PMID: 20678028; PMCID: PMC3197209.
    Citations: 31     Fields:    Translation:Humans
  13. Ghitza UE, Preston KL, Epstein DH, Kuwabara H, Endres CJ, Bencherif B, Boyd SJ, Copersino ML, Frost JJ, Gorelick DA. Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients. Biol Psychiatry. 2010 Oct 15; 68(8):697-703. PMID: 20579973.
    Citations: 32     Fields:    Translation:Humans
  14. Levin KH, Copersino ML, Heishman SJ, Liu F, Kelly DL, Boggs DL, Gorelick DA. Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. Drug Alcohol Depend. 2010 Sep 01; 111(1-2):120-7. PMID: 20510550.
    Citations: 63     Fields:    Translation:HumansAnimals
  15. Weiss RD, Potter JS, Copersino ML, Prather K, Jacobs P, Provost S, Chim D, Selzer J, Ling W. Conducting clinical research with prescription opioid dependence: defining the population. Am J Addict. 2010 Mar-Apr; 19(2):141-6. PMID: 20163386.
    Citations: 13     Fields:    Translation:Humans
  16. Potter JS, Prather K, Kropp F, Byrne M, Sullivan CR, Mohamedi N, Copersino ML, Weiss RD. A method to diagnose opioid dependence resulting from heroin versus prescription opioids using the Composite International Diagnostic Interview. Contemp Clin Trials. 2010 Mar; 31(2):185-8. PMID: 20079463.
    Citations: 6     Fields:    Translation:Humans
  17. Copersino ML, Fals-Stewart W, Fitzmaurice G, Schretlen DJ, Sokoloff J, Weiss RD. Rapid cognitive screening of patients with substance use disorders. Exp Clin Psychopharmacol. 2009 Oct; 17(5):337-44. PMID: 19803633.
    Citations: 37     Fields:    Translation:HumansPHPublic Health
  18. Kanneganti P, Copersino ML, Nelson RA, Boyd SJ, Ziegelstein RC, Gorelick DA. Signal-averaged electrocardiogram in physically healthy, recently abstinent chronic cocaine users. J Addict Med. 2009 Sep; 3(3):128-33. PMID: 21769008.
    Citations:    Fields:    
  19. Copersino ML, Meade CS, Bigelow GE, Brooner RK. Measurement of self-reported HIV risk behaviors in injection drug users: comparison of standard versus timeline follow-back administration procedures. J Subst Abuse Treat. 2010 Jan; 38(1):60-5. PMID: 19717270.
    Citations: 13     Fields:    Translation:Humans
  20. Heishman SJ, Evans RJ, Singleton EG, Levin KH, Copersino ML, Gorelick DA. Reliability and validity of a short form of the Marijuana Craving Questionnaire. Drug Alcohol Depend. 2009 Jun 01; 102(1-3):35-40. PMID: 19217724; PMCID: PMC2694410.
    Citations: 77     Fields:    Translation:Humans
  21. Copersino ML, Herning RI, Better W, Cadet JL, Gorelick DA. EEG and cerebral blood flow velocity abnormalities in chronic cocaine users. Clin EEG Neurosci. 2009 Jan; 40(1):39-42. PMID: 19278131.
    Citations:    Fields:    Translation:Humans
  22. Gorelick DA, Kim YK, Bencherif B, Boyd SJ, Nelson R, Copersino ML, Dannals RF, Frost JJ. Brain mu-opioid receptor binding: relationship to relapse to cocaine use after monitored abstinence. Psychopharmacology (Berl). 2008 Nov; 200(4):475-86. PMID: 18762918.
    Citations: 28     Fields:    Translation:HumansCells
  23. Levin KH, Copersino ML, Epstein D, Boyd SJ, Gorelick DA. Longitudinal ECG changes in cocaine users during extended abstinence. Drug Alcohol Depend. 2008 May 01; 95(1-2):160-3. PMID: 18242882.
    Citations: 6     Fields:    Translation:Humans
  24. Copersino ML, Jones H, Tuten M, Svikis D. Suicidal Ideation Among Drug-Dependent Treatment-Seeking Inner-City Pregnant Women. J Maint Addict. 2008 Jan 01; 3(2-4):53-64. PMID: 21796240.
    Citations: 12     
  25. Shi J, Zhao LY, Copersino ML, Fang YX, Chen Y, Tian J, Deng Y, Shuai Y, Jin J, Lu L. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users. Eur J Pharmacol. 2008 Jan 28; 579(1-3):160-6. PMID: 17977528.
    Citations: 35     Fields:    Translation:HumansCells
  26. McCarty D, Fuller B, Kaskutas LA, Wendt WW, Nunes EV, Miller M, Forman R, Magruder KM, Arfken C, Copersino M, Floyd A, Sindelar J, Edmundson E. Treatment programs in the National Drug Abuse Treatment Clinical Trials Network. Drug Alcohol Depend. 2008 Jan 01; 92(1-3):200-7. PMID: 17875368.
    Citations: 33     Fields:    Translation:Humans
  27. McCarty D, Fuller BE, Arfken C, Miller M, Nunes EV, Edmundson E, Copersino M, Floyd A, Forman R, Laws R, Magruder KM, Oyama M, Prather K, Sindelar J, Wendt WW. Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefs. Psychiatr Serv. 2007 Feb; 58(2):181-90. PMID: 17287373; PMCID: PMC2861362.
    Citations: 55     Fields:    Translation:Humans
  28. Killeen T, Carter R, Copersino M, Petry N, Stitzer M. Effectiveness of motivational incentives in stimulant abusing outpatients with different treatment histories. Am J Drug Alcohol Abuse. 2007; 33(1):129-37. PMID: 17366253.
    Citations: 6     Fields:    Translation:Humans
  29. Martins SS, Copersino ML, Soderstrom CA, Smith GS, Dischinger PC, McDuff DR, Hebel JR, Kerns TJ, Ho SM, Read KM, Gorelick DA. Risk of psychoactive substance dependence among substance users in a trauma inpatient population. J Addict Dis. 2007; 26(1):71-7. PMID: 17439870.
    Citations: 2     Fields:    Translation:Humans
  30. Vadhan NP, Carpenter KM, Copersino ML, Hart CL, Foltin RW, Nunes EV. Attentional bias towards cocaine-related stimuli: relationship to treatment-seeking for cocaine dependence. Am J Drug Alcohol Abuse. 2007; 33(5):727-36. PMID: 17891665.
    Citations: 22     Fields:    Translation:Humans
  31. Martins SS, Copersino ML, Soderstrom CA, Smith GS, Dischinger PC, McDuff DR, Hebel JR, Kerns TJ, Ho SM, Read KM, Gorelick DA. Sociodemographic characteristics associated with substance use status in a trauma inpatient population. J Addict Dis. 2007; 26(2):53-62. PMID: 17594998.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  32. Copersino ML, Boyd SJ, Tashkin DP, Huestis MA, Heishman SJ, Dermand JC, Simmons MS, Gorelick DA. Quitting among non-treatment-seeking marijuana users: reasons and changes in other substance use. Am J Addict. 2006 Jul-Aug; 15(4):297-302. PMID: 16867925.
    Citations: 36     Fields:    Translation:Humans
  33. Peirce JM, Petry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, Schwartz M, Krasnansky J, Pencer E, Silva-Vazquez L, Kirby KC, Royer-Malvestuto C, Roll JM, Cohen A, Copersino ML, Kolodner K, Li R. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch Gen Psychiatry. 2006 Feb; 63(2):201-8. PMID: 16461864.
    Citations: 188     Fields:    Translation:HumansPHPublic Health
  34. Copersino ML, Boyd SJ, Tashkin DP, Huestis MA, Heishman SJ, Dermand JC, Simmons MS, Gorelick DA. Cannabis withdrawal among non-treatment-seeking adult cannabis users. Am J Addict. 2006 Jan-Feb; 15(1):8-14. PMID: 16449088.
    Citations: 72     Fields:    Translation:Humans
  35. Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch Gen Psychiatry. 2005 Oct; 62(10):1148-56. PMID: 16203960.
    Citations: 211     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  36. Gorelick DA, Kim YK, Bencherif B, Boyd SJ, Nelson R, Copersino M, Endres CJ, Dannals RF, Frost JJ. Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Biol Psychiatry. 2005 Jun 15; 57(12):1573-82. PMID: 15953495.
    Citations: 62     Fields:    Translation:HumansCells
  37. Mintzer MZ, Copersino ML, Stitzer ML. Opioid abuse and cognitive performance. Drug Alcohol Depend. 2005 May 09; 78(2):225-30. PMID: 15845327.
    Citations: 49     Fields:    Translation:Humans
  38. Copersino ML, Serper MR, Vadhan N, Goldberg BR, Richarme D, Chou JC, Stitzer M, Cancro R. Cocaine craving and attentional bias in cocaine-dependent schizophrenic patients. Psychiatry Res. 2004 Oct 30; 128(3):209-18. PMID: 15541777.
    Citations: 23     Fields:    Translation:Humans
  39. Cumberbatch Z, Copersino M, Stitzer M, Jones H. Comparative drug use and psychosocial profiles of opioid dependents applying for medication versus medication-free treatment. Am J Drug Alcohol Abuse. 2004 May; 30(2):237-49. PMID: 15230074.
    Citations: 1     Fields:    Translation:Humans
  40. Copersino ML, Serper M, Allen MH. Emergency psychiatry: rapid screening for cognitive impairment in the psychiatric emergency service: II. A flexible test strategy. Psychiatr Serv. 2003 Mar; 54(3):314-6. PMID: 12610238.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  41. Serper MR, Bergman A, Copersino ML, Chou JC, Richarme D, Cancro R. Learning and memory impairment in cocaine-dependent and comorbid schizophrenic patients. Psychiatry Res. 2000 Feb 14; 93(1):21-32. PMID: 10699225.
    Citations: 11     Fields:    Translation:Humans
  42. Serper MR, Copersino ML, Richarme D, Vadhan N, Cancro R. Neurocognitive functioning in recently abstinent, cocaine-abusing schizophrenic patients. J Subst Abuse. 2000; 11(2):205-13. PMID: 10989779.
    Citations: 9     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Copersino's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (195)
Co-Authors (13)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.